Peer-reviewedPublisher termsThe Journal of Immunology Author Choice
Myeloid-derived suppressor cells in hematologic malignancies: A current state of the field
Related
- DECTIN1⁺ myeloid-derived suppressor cells mediate therapeutic effect of MSCs in haplo-HSCT for severe aplastic anemia
- CD200+ fibroblasts prime the immunoregulatory function of granulocytic myeloid-derived suppressor cells in inflammatory arthritis
- GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells
- Single-cell and bulk transcriptome-based identification of myeloid-derived suppressor cell-associated immune evasion signatures and a prognostic model for gastric cancer.
- In vivo monitoring of polymorphonuclear myeloid-derived suppressor cells in experimental rheumatoid arthritis
BibTeX
@article{nefedova2026myeloidderived,
title = {{Myeloid-derived suppressor cells in hematologic malignancies: A current state of the field}},
author = {Yulia Nefedova and Dmitry I Gabrilovich},
journal = {The Journal of Immunology Author Choice},
year = {2026},
month = oct,
doi = {10.1093/jimmun/vkag249},
url = {https://doi.org/10.1093/jimmun/vkag249},
}
RIS
TY - JOUR
TI - Myeloid-derived suppressor cells in hematologic malignancies: A current state of the field
AU - Yulia Nefedova
AU - Dmitry I Gabrilovich
PY - 2026
DA - 2026/10/09
JO - The Journal of Immunology Author Choice
DO - 10.1093/jimmun/vkag249
UR - https://doi.org/10.1093/jimmun/vkag249
SN - 0022-1767
SN - 1550-6606
ER -